Michael Lee Milligan

Insider Reports History

Location
C/O Neumora Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, MA
Signature
/s/ Michael Lee Milligan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Lee Milligan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Title: Chief Financial Officer & Principal Accounting Officer Common Stock 22.5K $38.1K $1.69 Feb 18, 2025 Direct
Neumora Therapeutics, Inc. Title: Chief Financial Officer & Principal Accounting Officer Stock Option (Right to Buy) 400K May 28, 2025 Direct

Insider Reports Filed by Michael Lee Milligan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NMRA Neumora Therapeutics, Inc. May 28, 2025 10 $0 4 May 30, 2025 Title: Chief Financial Officer & Principal Accounting Officer
NMRA Neumora Therapeutics, Inc. Feb 18, 2025 1 -$3.35K 4 Feb 20, 2025 Title: Chief Financial Officer & Principal Accounting Officer
NMRA Neumora Therapeutics, Inc. Feb 13, 2025 9 $0 4 Feb 18, 2025 Title: Chief Financial Officer & Principal Accounting Officer
NMRA Neumora Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 16, 2024 Title: SVP Finance & Principal Accounting Officer
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 0 $0 3 Sep 18, 2023 Title: SVP Finance & Principal Accounting Officer; Exhibit 24 - Power of Attorney